Shaping the battlefield: EGFR and KRAS tumor mutations’ role on the immune microenvironment and immunotherapy responses in lung cancer
2025 · Cancer and Metastasis Reviews · 9 citations
https://doi.org/10.1007/s10555-025-10272-4
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
1
Papers
10
Citations
1
h-index
1
i10-index
Tanvi Nandikonda is an academic researcher from University of Helsinki. The author has contributed to research in topics: Cancer Immunotherapy and Biomarkers & Lung Cancer Treatments and Mutations & Immunotherapy and Immune Responses. The author has an h-index of 1, co-authored 1 publications.
Click to start Chat